<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Endocarditis caused by Bartonella
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Endocarditis caused by Bartonella
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Endocarditis caused by Bartonella
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David H Spach, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen B Calderwood, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 22, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Bartonella
         </em>
         was first described as a cause of endocarditis in two separate reports in 1993 [
         <a href="#rid1">
          1,2
         </a>
         ] and has subsequently become appreciated as a significant cause of "culture-negative" endocarditis [
         <a href="#rid3">
          3-11
         </a>
         ]. In the United States,
         <em>
          Bartonella
         </em>
         is one of the most common, if not the most common, cause of culture-negative endocarditis.
        </p>
        <p>
         At least eight
         <em>
          Bartonella
         </em>
         species have been reported to cause infective endocarditis in humans:
         <em>
          B. quintana, B. henselae, B. elizabethae, B. vinsonii, B. koehlerae
         </em>
         ,
         <em>
          B
         </em>
         .
         <em>
          clarridgeiae
         </em>
         ,
         <em>
          B
         </em>
         .
         <em>
          washoensis
         </em>
         , and
         <em>
          B. alsatica
         </em>
         [
         <a href="#rid3">
          3,12-15
         </a>
         ]. However, more than 95 percent of the cases have involved either
         <em>
          B. quintana
         </em>
         or
         <em>
          B.
         </em>
         <em>
          henselae
         </em>
         .
        </p>
        <p>
         This topic will review the epidemiology, clinical manifestations, diagnosis, and treatment of
         <em>
          Bartonella
         </em>
         endocarditis. Other
         <em>
          Bartonella
         </em>
         infections are discussed in separate topic reviews. (See
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">
          "Bartonella infections in people with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5517.html" rel="external">
          "Bartonella quintana infections: Clinical features, diagnosis, and treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5516.html" rel="external">
          "South American bartonellosis: Oroya fever and verruga peruana"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The epidemiologic features of patients documented to have
         <em>
          Bartonella
         </em>
         endocarditis have varied considerably. Most reports have involved adults, although multiple cases have also been described in children [
         <a href="#rid10">
          10,16
         </a>
         ]. Overall, approximately 70 percent of reported cases have involved men [
         <a href="#rid11">
          11,17,18
         </a>
         ]. Case reports have also described
         <em>
          Bartonella
         </em>
         endocarditis in persons with HIV [
         <a href="#rid1">
          1
         </a>
         ], and there are rare reports of
         <em>
          Bartonella
         </em>
         endocarditis in persons who have undergone solid organ transplantation [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         Certain risk factors appear to be associated with
         <em>
          Bartonella
         </em>
         endocarditis. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Demographic factors and exposures
         </strong>
         – Available data suggest that lack of housing, alcohol use disorder, and infestation with body lice are associated with
         <em>
          B. quintana
         </em>
         endocarditis, whereas contact with cats serves as the major risk factor for
         <em>
          B. henselae
         </em>
         endocarditis [
         <a href="#rid3">
          3,4,18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Valvular heart disease
         </strong>
         – A significant proportion (approximately 40 to 60 percent) of persons with
         <em>
          Bartonella
         </em>
         endocarditis have prior cardiac valvular disease, particularly when
         <em>
          B
         </em>
         .
         <em>
          henselae
         </em>
         is the
         <em>
         </em>
         cause of the
         <em>
         </em>
         endocarditis [
         <a href="#rid3">
          3,11,20
         </a>
         ]. As an example, in a large series, which included 22 patients with
         <em>
          Bartonella
         </em>
         endocarditis, approximately 55 percent had evidence of pre-existing cardiac valvular disease [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">
          "Bartonella infections in people with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital heart disease
         </strong>
         – Multiple cases of
         <em>
          Bartonella
         </em>
         endocarditis have been reported that involved children, adolescents, and adults with congenital heart disease [
         <a href="#rid21">
          21-24
         </a>
         ]. The timely recognition and diagnosis of
         <em>
          Bartonella
         </em>
         endocarditis in persons with congenital heart disease are particularly important, since delayed diagnosis can have severe consequences, especially if repair of a valve or graft is required.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with
         <em>
          Bartonella
         </em>
         endocarditis have clinical manifestations similar to other patients with subacute bacterial endocarditis as described by the Duke criteria [
         <a href="#rid25">
          25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on '2023 Duke-ISCVID criteria'
         </a>
         .)
        </p>
        <p>
         The epidemiologic features of patients with documented
         <em>
          Bartonella
         </em>
         endocarditis are described above. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
         Affected patients typically present with subacute, nonspecific symptoms that include fever, fatigue, weakness, and weight loss. In addition, most patients have evidence of a murmur on cardiac auscultation. Based on reports from several case series, embolic events appear to be common with
         <em>
          Bartonella
         </em>
         endocarditis, but the true incidence is difficult to determine due to limited data [
         <a href="#rid3">
          3,11,17
         </a>
         ]. In some patients, one or more typical features of endocarditis, such as fever, elevated white blood cell count, and elevated erythrocyte sedimentation rate (ESR), may be absent [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         Although most cases involve native valves, case reports of prosthetic valve endocarditis have also been described. Such patients typically have an aggressive disease course characterized by valvular perforation or rapid progression of heart failure [
         <a href="#rid21">
          21,26,27
         </a>
         ].
        </p>
        <p>
         Patients with
         <em>
          Bartonella
         </em>
         endocarditis can also develop an immune-complex glomerulonephritis [
         <a href="#rid28">
          28-32
         </a>
         ]. Cases of anti-proteinase 3 (PR3)-positive glomerulonephritis in persons with
         <em>
          Bartonella
         </em>
         endocarditis have increasingly been reported in the past 10 years [
         <a href="#rid29">
          29,30,33,34
         </a>
         ]. Many of the cases present as a necrotizing antineutrophil cytoplasmic antibody (ANCA)-positive glomerulonephritis, associated with antibodies against PR3. In patients who initially present with glomerulonephritis and the cause is unknown, clinicians should consider evaluation for
         <em>
          Bartonella
         </em>
         endocarditis as a potential cause, especially if the patient has an epidemiologic risk for
         <em>
          Bartonella
         </em>
         , such as homelessness or cat exposure. (See
         <a class="medical medical_review" href="/z/d/html/3060.html" rel="external">
          "Clinical spectrum of antineutrophil cytoplasmic autoantibodies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2320684340">
         <span class="h1">
          FINDINGS ON ECHOCARDIOGRAPHY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Echocardiography shows valvular vegetations in approximately 90 percent of patients with
         <em>
          Bartonella
         </em>
         endocarditis [
         <a href="#rid11">
          11
         </a>
         ]. However, these vegetations do not appear to have unique or distinguishing features. (See
         <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">
          "Role of echocardiography in infective endocarditis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Cardiac imaging'
         </a>
         .)
        </p>
        <p>
         Approximately 60 percent of patients with
         <em>
          Bartonella
         </em>
         endocarditis have involvement of the aortic valve [
         <a href="#rid11">
          11
         </a>
         ]. Several cases have involved multiple valves, usually the aortic and mitral or the aortic and tricuspid valves. The reason for the apparent predilection to infect the aortic valve is unknown. Isolated right-sided endocarditis appears to occur infrequently [
         <a href="#rid11">
          11,35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          EVALUATION AND DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         This section will review the approach to diagnosis, as well as the different diagnostic tests that are used.
        </p>
        <p class="headingAnchor" id="H2191465452">
         <span class="h2">
          Approach to diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Bartonella
         </em>
         endocarditis should be suspected in patients with clinical and echocardiographic findings that suggest endocarditis if traditional blood cultures are negative after 72 to 96 hours of incubation and the patient has epidemiologic risk factors for
         <em>
          Bartonella
         </em>
         infection. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
         The evaluation of patients with possible
         <em>
          Bartonella
         </em>
         endocarditis should include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obtaining at least two sets of blood cultures for
         <em>
          Bartonella
         </em>
         . It is important to communicate with the microbiology laboratory to ensure special methods are used to optimize yield for growth of
         <em>
          Bartonella
         </em>
         species. (See
         <a class="local">
          'Culture'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serologic testing for
         <em>
          B. henselae
         </em>
         and
         <em>
          B. quintana
         </em>
         ; the test is highly predictive of endocarditis if there is a high titer for immunoglobulin G (IgG) antibodies to either of these species (eg, ≥1:1024 with the assay commonly used in the United States and ≥1:800 for the assay used in France) [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="local">
          'Serology'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum or plasma polymerase chain reaction (PCR) testing for
         <em>
          Bartonella
         </em>
         . (See
         <a class="local">
          'Polymerase chain reaction'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         For patients who undergo surgical removal of a cardiac valve,
         <em>
          Bartonella
         </em>
         PCR should be performed on the tissue sample. In addition, a Warthin-Starry stain should be performed if feasible, although this test is labor intensive and not routinely performed as a tissue histologic stain. (See
         <a class="local">
          'Polymerase chain reaction'
         </a>
         below and
         <a class="local">
          'Histopathology'
         </a>
         below.)
        </p>
        <p>
         A positive result for any of these tests should be considered a major Duke criterion for the diagnosis of
         <em>
          Bartonella
         </em>
         endocarditis [
         <a href="#rid17">
          17,36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on '2023 Duke-ISCVID criteria'
         </a>
         .)
        </p>
        <p>
         In a retrospective study of 348 patients with suspected blood culture-negative endocarditis,
         <em>
          Bartonella
         </em>
         spp were identified as the etiologic agent in 99 patients (28 percent) when serologic tests and direct PCR from valve specimens (when available) were utilized along with culture [
         <a href="#rid37">
          37
         </a>
         ]. In a subsequent prospective study involving 819 patients with culture-negative endocarditis [
         <a href="#rid38">
          38
         </a>
         ],
         <em>
          Bartonella
         </em>
         species accounted for the diagnosis in 86 (18 percent) of the 476 patients who had a specific pathogen identified when serologic and PCR testing was included in the diagnostic evaluation.
        </p>
        <p class="headingAnchor" id="H2791229256">
         <span class="h2">
          Considerations for those with glomerulonephritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Persons with
         <em>
          Bartonella
         </em>
         endocarditis who have evidence of glomerulonephritis should undergo evaluation for ANCA and proteinase 3 (PR3) antibodies. The diagnosis of immune-mediated glomerulonephritis is particularly important with
         <em>
          Bartonella
         </em>
         endocarditis, since use of an aminoglycoside as part of treatment of endocarditis would enhance the risk of nephrotoxicity in this setting.
        </p>
        <p class="headingAnchor" id="H1728417152">
         <span class="h2">
          Diagnostic tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of
         <em>
          Bartonella
         </em>
         endocarditis often requires modalities other than blood culture to identify the organism. Blood cultures require prolonged incubation before they turn positive, if they turn positive at all [
         <a href="#rid3">
          3,37,38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2876183439">
         <span class="h3">
          Culture
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Bartonella
         </em>
         species are fastidious gram-negative bacteria that require specific laboratory conditions for optimal growth. In a multicenter international study, only 5 of the 22 patients diagnosed with
         <em>
          Bartonella
         </em>
         endocarditis (approximately 25 percent) had a positive blood culture at any time in their clinical course [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Ideally, blood culture samples should be collected in pediatric or adult isolator tubes (Wampole, Cranbury, New Jersey), or in blood tubes containing ethylenediamine tetra-acetic acid (EDTA). The blood culture sample should then be added onto an agar plate that contains both chocolate agar (to optimize isolation of
         <em>
          B
         </em>
         .
         <em>
          quintana
         </em>
         ) and heart infusion agar supplemented with 5 percent rabbit blood (to optimize isolation of
         <em>
          B
         </em>
         .
         <em>
          henselae
         </em>
         ). The addition of a source of heme, such as rabbit blood, is important since
         <em>
          Bartonella
         </em>
         species require heme for growth [
         <a href="#rid39">
          39
         </a>
         ]. The microbiology laboratory should use fresh agar plates (within seven days after pouring) and incubate the samples in 5 percent CO
         <sub>
          2
         </sub>
         at 35 to 37°C for a minimum of 28 days. If growth of colonies is detected, then subcultures should be performed and growth of
         <em>
          Bartonella
         </em>
         colonies in the subcultures typically occurs within seven days [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         <em>
          Bartonella
         </em>
         species have also occasionally been isolated from BACTEC bottles, and by blind subculture of BACTEC bottle cultures, followed by acridine orange staining and subculture on chocolate and heart infusion agar supplemented with rabbit blood [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         Isolation of
         <em>
          Bartonella
         </em>
         from cardiac valvular tissue samples has a very low yield, but if attempted, tissue homogenates should be directly plated onto agar and cocultivated with a bovine endothelial cell monolayer [
         <a href="#rid42">
          42
         </a>
         ]. When trying to culture
         <em>
          Bartonella
         </em>
         , it is important to proactively communicate with the microbiology laboratory so they can optimize culture techniques and can extend the incubation period for a minimum of 28 days.
        </p>
        <p class="headingAnchor" id="H1156107724">
         <span class="h3">
          Polymerase chain reaction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Qualitative polymerase chain reaction (PCR) testing is performed by amplifying a 296 base pair fragment of the 16S ribosomal RNA. Multiple commercial laboratories now offer PCR testing for
         <em>
          Bartonella
         </em>
         on tissue or blood samples, but only some differentiate
         <em>
          B. quintana
         </em>
         from
         <em>
          B. henselae
         </em>
         .
        </p>
        <p>
         The use of PCR-based tests on cardiac valvular tissue has played an important role in the diagnosis of
         <em>
          Bartonella
         </em>
         endocarditis [
         <a href="#rid20">
          20,43
         </a>
         ]. As an example, in one study, investigators reported positive PCR testing for
         <em>
          Bartonella
         </em>
         on cardiac valve tissue in greater than 95 percent of patients with
         <em>
          Bartonella
         </em>
         endocarditis [
         <a href="#rid20">
          20
         </a>
         ]. The organism was detected even though more than 60 percent of these patients had their valves analyzed following the receipt of antibiotics. Although paraffin-embedded specimens can be used, the yield appears to be greater using fresh valvular tissue.
        </p>
        <p>
         PCR testing can also be performed on whole blood, plasma, or serum samples. In one study, investigators performed
         <em>
          Bartonella
         </em>
         PCR testing of serum samples taken from patients with a diagnosis of
         <em>
          Bartonella
         </em>
         endocarditis (based upon serologic, culture, and/or molecular detection in valvular tissue) [
         <a href="#rid44">
          44
         </a>
         ]. In such patients, serum PCR testing demonstrated a sensitivity and specificity of 58 and 100 percent, respectively. In a French review of 106 cases of
         <em>
          Bartonella
         </em>
         endocarditis, PCR testing had a sensitivity of 92 percent for valvular biopsy specimens, 36 percent for serum samples, and 33 percent for blood samples [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Serology
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with suspected
         <em>
          Bartonella
         </em>
         endocarditis, serologic testing can play a supportive role in the appropriate clinical setting. In the United States,
         <em>
          Bartonella
         </em>
         serology testing is commercially available from a number of laboratories.
        </p>
        <p>
         Indirect immunofluorescence assay (IFA) is the preferred and the most commonly used serologic method for diagnosing
         <em>
          Bartonella
         </em>
         infections. For persons with suspected
         <em>
          Bartonella
         </em>
         endocarditis, we rely predominantly on IFA IgG titer and not IgM titers. Available data suggest that IgM antibody titers to
         <em>
          Bartonella
         </em>
         are often negative in persons with
         <em>
          Bartonella
         </em>
         endocarditis and therefore are not considered a reliable diagnostic test in this setting [
         <a href="#rid36">
          36
         </a>
         ]. One study found that Western immunoblotting had a very high sensitivity and specificity for identifying the causative species in cases of
         <em>
          Bartonella
         </em>
         endocarditis, but this test is not readily available [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
         There are several limitations to serologic testing. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lack of uniform diagnostic criteria
         </strong>
         – Clearly defined, uniform cut-off titers for a positi
         <em>
          ve Bartonella
         </em>
         serology do not exist since there are subtle differences in the IFA assays used, and the predictive values of titers in relation to the different clinical manifestations and diseases caused by
         <em>
          Bartonella
         </em>
         infection can vary. As an example, although most laboratories in the United States consider an IgG titer of ≥1:64 or ≥1:128 to either
         <em>
          B. henselae
         </em>
         or
         <em>
          B. quintana
         </em>
         as a positive IgG test, persons with
         <em>
          Bartonella
         </em>
         endocarditis typically have
         <em>
         </em>
         a
         <em>
          Bartonella
         </em>
         IgG serologic titer of ≥1:1024. This titer of 1:1024 is roughly equivalent to an IgG titer of 1:800 for the assay used in French laboratories, where much of the endocarditis literature has been published [
         <a href="#rid17">
          17,36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, these suggested cut-off values should not be considered rigid diagnostic criteria. Several studies have shown a substantial percentage of persons with Bartonella endocarditis will have IgG values below these suggested cut-offs [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cross-reactivity
         </strong>
         – Significant cross-reactivity occurs at the species level betwe
         <em>
          en B. henselae
         </em>
         and
         <em>
          B. quintana,
         </em>
         as well as with some other
         <em>
          Bartonella
         </em>
         species
         <em>
         </em>
         [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Cross-reactions can also occur between Bartonella and Chlamydia spp. In one series, nine patients previously thought to have Chlamydia endocarditis were reclassified as Bartonella endocarditis based on cross-adsorption studies [
         <a href="#rid3">
          3
         </a>
         ]. The process of cross-adsorption consists of incubating patient serum with the bacteria suspected of causing cross-reaction in the serologic test. The adsorption process removes antibodies to the bacterium that caused serologic cross-reaction, but the antibodies to the organism causing the disease remain.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Among patients with Bartonella endocarditis, there is frequent cross-reactivity with Coxiella antigens, which can produce a false-positive result for Coxiella (but it is usually Phase II antibodies and does not increase with time). Further information regarding Q fever can be found on the United States
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.cdc.gov%252Fqfever%252Fhealthcare-providers%252Findex.html%26data%3D05%7C01%7CMaryKate.Durante%2540wolterskluwer.com%7C21912dd3016a4648fbe808dae1cb832b%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638070561442028992%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C3000%7C%7C%7C%26sdata%3DL6HGCTAa5Fi9L2hoDtC%252F%252FoT7Hf05C8f4iPkYgx6OuKg%253D%26reserved%3D0&amp;token=l4zKXWAWHLzGiNcbRJ0ffJB%2Brwpg9LfmE%2BzWDcotTpgTM%2FDwkvrARLHU4ZWoZGeIrx7BeATbWcpSXx37RGSjDMnQYFCoLwdPu9jkYcLb9KGAwi5CvbOp9uR5QPaa5RD2yQtXHaWami664PmMlb9QQAbqwR37vbgzdvroyTBZ9R4Q85RBkuif%2FH6ISgFp%2F4gxuEPTmPJK1pgqPYCNGzTD6JUzbf4aGhvNvBnwwaMo0%2FscGJL%2BEyijuqoVIdWbb9z1O5IEwjL4JA%2FzGxbEzcmAImr%2FKF7Tot%2Ff6ie8xwI2LhVvXKg%2FaPi0ao8y%2F4PsUnomu8M5sTO5vSaQfpNus0cy5KgyibmSIpw3bX7uJgA5Ui2n1mw2KilncZxXfuaFHjQG4U7iPSTHFDwKHCtF7FOBxDHbBeahjj5OdGWFz3Fk2cpgLc4L%2B7d6TkeY2xY0yTx8ta5Tl68HuNhz5CEi%2FZAY3Q%3D%3D&amp;TOPIC_ID=2145" target="_blank">
          Centers for Disease Control and Prevention website
         </a>
         [
         <a href="#rid46">
          46,47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4109523117">
         <span class="h3">
          Histopathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cardiac valvular tissue stained with hematoxylin and eosin characteristically shows mildly inflamed connective tissue with focal granulation tissue reaction [
         <a href="#rid4">
          4
         </a>
         ]. Warthin-Starry silver staining of these aggregates, if positive, reveals masses of small, dark-staining bacteria. When electron microscopy is performed, pleomorphic bacilli are seen predominantly located intracellularly [
         <a href="#rid3">
          3
         </a>
         ]. Gram staining of cardiac valvular tissue is not useful for diagnosing
         <em>
          Bartonella
         </em>
         endocarditis.
        </p>
        <p>
         In one study of 15 patients with confirmed
         <em>
          Bartonella
         </em>
         endocarditis, the cardiac valve pathology showed more fibrotic and calcified changes, less vascularization, and less extensive vegetations; these features suggested chronic infection when compared with cases of infective endocarditis caused by other pathogens [
         <a href="#rid48">
          48
         </a>
         ]. In addition, approximately 11 (85 percent) of 13 had a positive Warthin-Starry stain of the valve tissue and 10 (77 percent) of the 13 had a positive
         <em>
          Bartonella
         </em>
         immunohistologic test.
        </p>
        <p class="headingAnchor" id="H1834566430">
         <span class="h1">
          ANTIMICROBIAL THERAPY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mainstay of treatment for
         <em>
          Bartonella
         </em>
         endocarditis is antimicrobial therapy. In some patients, surgical management may be required as well. The indications for surgery in patients with
         <em>
          Bartonella
         </em>
         endocarditis are the same as for other causes of infectious endocarditis. (See
         <a class="local">
          'Surgery'
         </a>
         below.)
        </p>
        <p>
         There are insufficient data to guide definitive recommendations for treating
         <em>
          Bartonella
         </em>
         endocarditis since there are no randomized trials; the existing literature consists of case series and case reports [
         <a href="#rid3">
          3,11,17
         </a>
         ]. In addition, most patients with
         <em>
          Bartonella
         </em>
         endocarditis have undergone cardiac valvular surgery with removal of the infected valve, making it difficult to assess the separate role of antibiotics.
        </p>
        <p>
         Treatment guidelines for suspected and proven
         <em>
          Bartonella
         </em>
         endocarditis were put forth by an expert panel in 2004 [
         <a href="#rid40">
          40
         </a>
         ] and were subsequently incorporated into the 2005 American Heart Association Infective Endocarditis guidelines [
         <a href="#rid49">
          49
         </a>
         ]. The 2015 American Heart Association endocarditis guidelines have not provided specific treatment recommendations for
         <em>
          Bartonella
         </em>
         endocarditis [
         <a href="#rid50">
          50
         </a>
         ]. The following recommendations differ from the 2004 expert panel recommendations based on more recent data regarding renal disease in persons with
         <em>
          Bartonella
         </em>
         endocarditis, particularly
         <em>
          Bartonella
         </em>
         -associated anti-proteinase 3 (PR3)-positive glomerulonephritis [
         <a href="#rid29">
          29,30,33,34
         </a>
         ]. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H188193291">
         <span class="h2">
          Preferred regimen
         </span>
         <span class="headingEndMark">
          —
         </span>
         For nonpregnant adults with confirmed
         <em>
          Bartonella
         </em>
         endocarditis, we suggest combination therapy with
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         and
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         . Considerations for pregnant women and young children are discussed below. (See
         <a class="local">
          'Considerations in pregnant persons and young children'
         </a>
         below.)
        </p>
        <p>
         The dosing and duration of these agents are as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          Doxycycline
         </a>
         (100 mg orally or intravenous [IV] every 12 hours) should be administered for three months.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          Rifampin
         </a>
         (300 mg orally or IV every 12 hours) should be administered for the first six weeks of therapy.
        </p>
        <p>
        </p>
        <p>
         If a patient with culture-negative endocarditis has suspected, but not proven,
         <em>
          Bartonella
         </em>
         infection, an additional agent, ideally
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         (2 g IV once daily for six weeks), should be added to cover other likely causes of culture-negative endocarditis. Although ceftriaxone probably has some activity against
         <em>
          Bartonella
         </em>
         [
         <a href="#rid51">
          51
         </a>
         ], its role in this setting is primarily to treat common culture-negative endocarditis pathogens that are not effectively treated by
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">
          "Antimicrobial therapy of left-sided native valve endocarditis", section on 'Culture-negative endocarditis'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          Doxycycline
         </a>
         is the key component of therapy for
         <em>
          Bartonella
         </em>
         endocarditis, based on available reports describing treatment of
         <em>
          Bartonella
         </em>
         endocarditis and other types of
         <em>
          Bartonella
         </em>
         infections [
         <a href="#rid52">
          52-54
         </a>
         ]. However, since doxycycline is bacteriostatic, we suggest that it be used in combination with a second antimicrobial and administered for a prolonged duration. The use of a prolonged three-month course of doxycycline for
         <em>
          Bartonella
         </em>
         endocarditis is also based on the lack of definitive data on treatment duration, the intracellular location of
         <em>
          Bartonella
         </em>
         , and the relatively low risk of developing serious adverse reactions with an extended course of oral doxycycline.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          Rifampin
         </a>
         should ideally be included as the second antimicrobial in combination with
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         . Although there are no studies that have examined use of rifampin in combination with a
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         for the treatment of
         <em>
          Bartonella
         </em>
         endocarditis, rifampin has excellent intracellular penetration, which is important when treating
         <em>
          Bartonella
         </em>
         infections, particularly
         <em>
          Bartonella
         </em>
         endocarditis. In addition, rifampin has been shown to be effective as a component of therapy with other serious
         <em>
          Bartonella
         </em>
         infections. Previously,
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         had been the preferred second agent, but we now consider gentamicin an alternative for those who cannot take rifampin (eg, due to drug interactions) given the significant risk of nephrotoxicity. (See
         <a class="local">
          'Alternative regimens'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H303668643">
         <span class="h2">
          Alternative regimens
         </span>
         <span class="headingEndMark">
          —
         </span>
         The approach to choosing an alternative regimen for patients with confirmed
         <em>
          Bartonella
         </em>
         endocarditis depends upon why the patient cannot take the preferred regimen.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          If
         </strong>
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         <strong>
          cannot be used
         </strong>
         – For patients who are intolerant to doxycycline,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         (500 mg IV/orally once daily) for three months is an alternative agent. However, the efficacy of macrolides is likely lower compared with tetracyclines for the treatment of
         <em>
          Bartonella
         </em>
         endocarditis [
         <a href="#rid40">
          40
         </a>
         ]. Considerations for regimen selection in pregnant women and young children are discussed below. (See
         <a class="local">
          'Considerations in pregnant persons and young children'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Similar to
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         should be administered with a second agent (preferably
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         ). (See
         <a class="local">
          'Preferred regimen'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          If
         </strong>
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         <strong>
          cannot be used
         </strong>
         – For patients who cannot use rifampin (eg, due to drug interactions),
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         plus
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         is a reasonable alternative in those with normal renal function and no evidence of
         <em>
          Bartonella
         </em>
         -associated glomerulonephritis. The preferred dose of gentamicin is 3 mg/kg/day given once daily for the initial 14 days of therapy; however, some experts dose gentamicin as 1 mg/kg IV every eight hours since this dosing regimen has been used in most of the
         <em>
          Bartonella
         </em>
         endocarditis case reports. The once-daily gentamicin dose should be adjusted, if needed, to achieve trough serum concentrations of &lt;1 mcg/mL. If every-eight-hour dosing is used, doses should be adjusted to achieve peak serum concentrations of 3 to 4 mcg/mL and trough concentrations less than 1 mcg/ml; the peak level should be obtained one hour after administration and the trough level 24 hours after the first dose and then twice weekly thereafter. In addition, renal function should be monitored closely. The benefit of including aminoglycoside therapy was supported in a retrospective analysis of 101 patients with
         <em>
          Bartonella
         </em>
         endocarditis that found persons who received a regimen that included at least 14 days of an aminoglycoside had higher recovery and survival rates compared with those who were treated with a regimen without an aminoglycoside [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For those who cannot receive either
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         or
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         as the second agent, a less preferable option is monotherapy with
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         alone. However, in this setting we extend the duration of treatment for Bartonella endocarditis to six months. If doxycycline cannot be used, then
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         should be given for six months.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1371796674">
         <span class="h2">
          Considerations in pregnant persons and young children
         </span>
         <span class="headingEndMark">
          —
         </span>
         When choosing a treatment regimen for
         <em>
          Bartonella
         </em>
         endocarditis in pregnant persons and children &lt;8 years of age, the benefit of using a regimen that contains
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (the preferred regimen for treatment of
         <em>
          Bartonella
         </em>
         endocarditis) must be weighed against potential antimicrobial toxicity. Pregnant persons should be managed in consultation with a maternal-fetal medicine specialist.
        </p>
        <p>
         Since there are no data to guide treatment decisions in these patient groups, the following key points related to the risks and benefits of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         should be considered when determining the treatment regimen.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The tetracyclines are a key component of therapy for
         <em>
          Bartonella
         </em>
         endocarditis, which can be a life-threatening disease. Evidence supporting the use of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         is discussed above. (See
         <a class="local">
          'Preferred regimen'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          Azithromycin
         </a>
         , which is considered safe for use in pregnancy and in young children, is the best option as an alternative to
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         to treat
         <em>
          Bartonella
         </em>
         endocarditis. However, there is less experience with macrolides for treatment of endocarditis, and in general, they are felt to be less effective than doxycycline. (See
         <a class="local">
          'Alternative regimens'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The use of tetracyclines are generally contraindicated in pregnancy because of the risk of hepatotoxicity in the mother [
         <a href="#rid55">
          55
         </a>
         ] and adverse effects on fetal bone and teeth [
         <a href="#rid56">
          56,57
         </a>
         ]. Subsequent evidence has suggested the relative safety of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         compared with older tetracyclines in both pregnant women and children when a short course is used [
         <a href="#rid58">
          58,59
         </a>
         ]. These studies, however, are low quality and insufficient to conclude that there is no risk. In addition, it is unclear if these findings can be applied to the longer courses required for treatment of endocarditis. (See
         <a class="medical medical_review" href="/z/d/html/494.html" rel="external">
          "Tetracyclines", section on 'Pregnant or breastfeeding women'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          Tetracycline
         </a>
         antibiotics have been associated with permanent tooth discoloration in children less than eight years of age if used repeatedly or for prolonged courses. However,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         binds less readily to calcium than other tetracyclines, and the risk of dental staining with doxycycline is minimal if a short course is administered [
         <a href="#rid58">
          58,60-62
         </a>
         ]. The American Academy of Pediatrics permits use of doxycycline for ≤21 days in children of all ages [
         <a href="#rid63">
          63
         </a>
         ], but there are limited safety data when doxycycline is used for &gt;21 days in children less than eight years of age. (See
         <a class="medical medical_review" href="/z/d/html/494.html" rel="external">
          "Tetracyclines", section on 'Young children'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2996674698">
         <span class="h1">
          SURGERY
         </span>
        </p>
        <p class="headingAnchor" id="H1141537554">
         <span class="h2">
          Indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         The indications for surgery in patients with
         <em>
          Bartonella
         </em>
         endocarditis are the same as for other causes of infectious endocarditis. The one exception is the indication based upon persistently positive blood cultures (longer than five to seven days despite appropriate antimicrobial therapy) [
         <a href="#rid50">
          50
         </a>
         ]. Persistent bacteremia is not a feasible indicator to use in patients with
         <em>
          Bartonella
         </em>
         endocarditis, due to the prolonged time required for growth of
         <em>
          Bartonella
         </em>
         species in blood cultures. Topic reviews that discuss the indications for surgery in patients with endocarditis are presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">
          "Surgery for left-sided native valve infective endocarditis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2132.html" rel="external">
          "Surgery for prosthetic valve endocarditis"
         </a>
         .)
        </p>
        <p>
         In case reports of patients with
         <em>
          Bartonella
         </em>
         endocarditis, approximately 60 percent have undergone cardiac valvular surgery during initial hospitalization [
         <a href="#rid3">
          3,4,20
         </a>
         ]. The reason for the high proportion of patients undergoing valvular surgery is not precisely known but is thought to result primarily from the higher incidence of pre-existing valvular abnormalities, the indolent course, and delayed diagnosis [
         <a href="#rid11">
          11,17,40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1878355855">
         <span class="h2">
          Implications for antimicrobial therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some patients with
         <em>
          Bartonella
         </em>
         endocarditis undergo cardiac valvular surgery and the infected valve(s) is removed. This can impact the approach to antimicrobial therapy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          If antimicrobial therapy was initiated prior to surgery
         </strong>
         – If antimicrobial therapy was started prior to surgery, the remaining course of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         plus
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         therapy should be completed post-operatively (ie, the patient receives a total of three months of doxycycline and six weeks of rifampin).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, there are a few situations in which this approach may need to be modified:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If the patient was receiving
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         and had not completed the two-week course of gentamicin prior to surgery, we do not continue gentamicin post-operatively. This is due to the enhanced risk of nephrotoxicity with an aminoglycoside during and following cardiac surgery and the likelihood that the burden of infection was reduced with the previous antibiotics and the removal of the valve.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If there were &lt;2 weeks of the treatment regimen remaining, or if the entire antimicrobial course had been completed prior to cardiac surgery, we give an additional two weeks of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         post-operatively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          If the diagnosis is made post-operatively
         </strong>
         – On occasion, a diagnosis of
         <em>
          Bartonella
         </em>
         endocarditis is made post-operatively and the patient has not received pre-operative antimicrobial therapy. In this situation, a six-week course of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         plus
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         may be sufficient, assuming all infected valve tissue has been removed. If rifampin cannot be used, then
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         should be used for the initial 14 days of therapy as an alternative but with very careful monitoring.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1018428179">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112042.html" rel="external">
          "Society guideline links: Treatment and prevention of infective endocarditis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology/epidemiology
         </strong>
         – Six species of
         <em>
          Bartonella
         </em>
         have been reported to cause infective endocarditis in humans, although the vast majority of cases have involved either
         <em>
          B. quintana
         </em>
         or
         <em>
          B. henselae
         </em>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Homelessness, alcoholism, and infestation with body lice are associated with
         <em>
          B. quintana
         </em>
         endocarditis, whereas contact with cats and previous valvular disease are the major risk factors for
         <em>
          B. henselae
         </em>
         endocarditis. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Patients with
         <em>
          Bartonella
         </em>
         endocarditis present with fever, fatigue, weakness, and weight loss, similar to those with other forms of subacute bacterial endocarditis. Most also have evidence of a murmur on cardiac auscultation. Patients with
         <em>
          Bartonella
         </em>
         endocarditis can also develop an immune-complex glomerulonephritis. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation and diagnosis
         </strong>
         –
         <em>
          Bartonella
         </em>
         endocarditis should be suspected in patients with clinical and echocardiographic findings that suggest endocarditis if traditional blood cultures are negative after 72 to 96 hours and the patient has epidemiologic risk factors for disease. The initial evaluation of patients with possible
         <em>
          Bartonella
         </em>
         endocarditis should include the following (see
         <a class="local">
          'Evaluation and Diagnosis'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Blood cultures using special methods to optimize growth. (See
         <a class="local">
          'Culture'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Serologic testing using either an indirect immunofluorescence assay (IFA) or an enzyme-linked immunosorbent assay (ELISA). A high titer for IgG antibodies (eg, ≥1:1024 with the assay commonly used in the United States) to either
         <em>
          B. henselae
         </em>
         or
         <em>
          B. quintana
         </em>
         strongly suggests a diagnosis of
         <em>
          Bartonella
         </em>
         endocarditis. (See
         <a class="local">
          'Serology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polymerase chain reaction (PCR)-based testing for
         <em>
          Bartonella
         </em>
         on serum or plasma. (See
         <a class="local">
          'Polymerase chain reaction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients with culture-negative endocarditis who undergo cardiac valve replacement, PCR-based testing for
         <em>
          Bartonella
         </em>
         should be performed on the cardiac valvular tissue. In addition, the tissue should be stained with Warthin-Starry silver staining, which may demonstrate masses of small, dark-staining bacteria. (See
         <a class="local">
          'Polymerase chain reaction'
         </a>
         above and
         <a class="local">
          'Histopathology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antimicrobial therapy
         </strong>
         –
         <strong>
         </strong>
         The mainstay of treatment for
         <em>
          Bartonella
         </em>
         endocarditis is antimicrobial therapy. In some patients, surgical management may be required as well. Treatment recommendations are based upon case series and case reports.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For nonpregnant adults with proven
         <em>
          Bartonella
         </em>
         endocarditis, we suggest treatment with
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg orally or intravenous [IV] every 12 hours for three months) plus
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         (300 mg orally or IV every 12 hours for the first six weeks of therapy) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Preferred regimen'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For those who cannot take
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         (eg, 3 mg/kg IV every 24 hours for 14 days) is a reasonable alternative for those with normal kidney function. A less preferred option is
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         alone for six months if the patient cannot take rifampin or gentamicin. (See
         <a class="local">
          'Alternative regimens'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients who are intolerant of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         can be used; however, macrolides should not be viewed as equivalent to tetracyclines for the treatment of
         <em>
          Bartonella
         </em>
         endocarditis. For pregnant women and young children, the decision to use a prolonged course of doxycycline versus azithromycin must be determined on a case-by-case basis. (See
         <a class="local">
          'Alternative regimens'
         </a>
         above and
         <a class="local">
          'Considerations in pregnant persons and young children'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgery
         </strong>
         – The indications for surgery in patients with
         <em>
          Bartonella
         </em>
         endocarditis are generally the same as for other causes of infectious endocarditis. However, the timing of surgery may impact the choice and duration of antimicrobial therapy. (See
         <a class="local">
          'Surgery'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Spach DH, Callis KP, Paauw DS, et al. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol 1993; 31:692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 1993; 31:872.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raoult D, Fournier PE, Drancourt M, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 1996; 125:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spach DH, Kanter AS, Daniels NA, et al. Bartonella (Rochalimaea) species as a cause of apparent "culture-negative" endocarditis. Clin Infect Dis 1995; 20:1044.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmes AH, Greenough TC, Balady GJ, et al. Bartonella henselae endocarditis in an immunocompetent adult. Clin Infect Dis 1995; 21:1004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drancourt M, Birtles R, Chaumentin G, et al. New serotype of Bartonella henselae in endocarditis and cat-scratch disease. Lancet 1996; 347:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hadfield TL, Warren R, Kass M, et al. Endocarditis caused by Rochalimaea henselae. Hum Pathol 1993; 24:1140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jalava J, Kotilainen P, Nikkari S, et al. Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis 1995; 21:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breathnach AS, Hoare JM, Eykyn SJ. Culture-negative endocarditis: contribution of bartonella infections. Heart 1997; 77:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baorto E, Payne RM, Slater LN, et al. Culture-negative endocarditis caused by Bartonella henselae. J Pediatr 1998; 132:1051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raoult D, Fournier PE, Vandenesch F, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med 2003; 163:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avidor B, Graidy M, Efrat G, et al. Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. J Clin Microbiol 2004; 42:3462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raoult D, Roblot F, Rolain JM, et al. First isolation of Bartonella alsatica from a valve of a patient with endocarditis. J Clin Microbiol 2006; 44:278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Logan JMJ, Hall JL, Chalker VJ, et al. Bartonella clarridgeiae infection in a patient with aortic root abscess and endocarditis. Access Microbiol 2019; 1:e000064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Loewenich FD, Seckert C, Dauber E, et al. Prosthetic Valve Endocarditis with Bartonella washoensis in a Human European Patient and Its Detection in Red Squirrels (Sciurus vulgaris). J Clin Microbiol 2019; 58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Posfay Barbe K, Jaeggi E, Ninet B, et al. Bartonella quintana endocarditis in a child. N Engl J Med 2000; 342:1841.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edouard S, Nabet C, Lepidi H, et al. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol 2015; 53:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghidey FY, Igbinosa O, Mills K, et al. Case series of Bartonella quintana blood culture-negative endocarditis in Washington, DC. JMM Case Rep 2016; 3:e005049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Psarros G, Riddell J 4th, Gandhi T, et al. Bartonella henselae infections in solid organ transplant recipients: report of 5 cases and review of the literature. Medicine (Baltimore) 2012; 91:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fournier PE, Lelievre H, Eykyn SJ, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) 2001; 80:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abandeh FI, Bazan JA, Davis JA, et al. Bartonella henselae prosthetic valve endocarditis in an adult patient with congenital heart disease: favorable outcome after combined medical and surgical management. J Card Surg 2012; 27:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ouellette CP, Joshi S, Texter K, Jaggi P. Multiorgan Involvement Confounding the Diagnosis of Bartonella henselae Infective Endocarditis in Children With Congenital Heart Disease. Pediatr Infect Dis J 2017; 36:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Georgievskaya Z, Nowalk AJ, Randhawa P, Picarsic J. Bartonella henselae endocarditis and glomerulonephritis with dominant C3 deposition in a 21-year-old male with a Melody transcatheter pulmonary valve: case report and review of the literature. Pediatr Dev Pathol 2014; 17:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olarte L, Ampofo K, Thorell EA, et al. Bartonella vinsonii endocarditis in an adolescent with congenital heart disease. Pediatr Infect Dis J 2012; 31:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fowler VG, Durack DT, Selton-Suty C, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis 2023; 77:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein JL, Nair SK, Harrison TG, et al. Prosthetic valve endocarditis caused by Bartonella quintana. Emerg Infect Dis 2002; 8:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kreisel D, Pasque MK, Damiano RJ Jr, et al. Bartonella species-induced prosthetic valve endocarditis associated with rapid progression of valvular stenosis. J Thorac Cardiovasc Surg 2005; 130:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khalighi MA, Nguyen S, Wiedeman JA, Palma Diaz MF. Bartonella endocarditis-associated glomerulonephritis: a case report and review of the literature. Am J Kidney Dis 2014; 63:1060.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Haare Heijmeijer S, Wilmes D, Aydin S, et al. Necrotizing ANCA-Positive Glomerulonephritis Secondary to Culture-Negative Endocarditis. Case Rep Nephrol 2015; 2015:649763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raybould JE, Raybould AL, Morales MK, et al. Bartonella Endocarditis and Pauci-Immune Glomerulonephritis: A Case Report and Review of the Literature. Infect Dis Clin Pract (Baltim Md) 2016; 24:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vercellone J, Cohen L, Mansuri S, et al. Bartonella Endocarditis Mimicking Crescentic Glomerulonephritis with PR3-ANCA Positivity. Case Rep Nephrol 2018; 2018:9607582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babiker A, El Hag MI, Perez C. Bartonella Infectious Endocarditis Associated With Cryoglobulinemia and Multifocal Proliferative Glomerulonephritis. Open Forum Infect Dis 2018; 5:ofy186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cervi A, Kelly D, Alexopoulou I, Khalidi N. ANCA-associated pauci-immune glomerulonephritis in a patient with bacterial endocarditis: a challenging clinical dilemma. Clin Nephrol Case Stud 2017; 5:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aslangul E, Goulvestre C, Mallat Z, Mainardi JL. Human bartonella infective endocarditis is associated with high frequency of antiproteinase 3 antibodies. J Rheumatol 2014; 41:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruneel F, D'estanque J, Fournier PE, et al. Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult. Scand J Infect Dis 1998; 30:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fournier PE, Mainardi JL, Raoult D. Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis. Clin Diagn Lab Immunol 2002; 9:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005; 84:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010; 51:131.
          </a>
         </li>
         <li class="breakAll">
          Dumler JS, Carroll KC, Patel R. Bartonella. In: Manual of Clinical Microbiology, 12th ed, Carroll KC, Pfaller MA, Landry ML, et al (Eds), Wiley, 2019.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eremeeva ME, Gerns HL, Lydy SL, et al. Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N Engl J Med 2007; 356:2381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris KA, Yam T, Jalili S, et al. Service evaluation to establish the sensitivity, specificity and additional value of broad-range 16S rDNA PCR for the diagnosis of infective endocarditis from resected endocardial material in patients from eight UK and Ireland hospitals. Eur J Clin Microbiol Infect Dis 2014; 33:2061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeaiter Z, Fournier PE, Greub G, Raoult D. Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum. J Clin Microbiol 2003; 41:919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Houpikian P, Raoult D. Western immunoblotting for Bartonella endocarditis. Clin Diagn Lab Immunol 2003; 10:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson A, Bijlmer H, Fournier PE, et al. Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 2013; 62:1.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Q fever: Information for Healthcare Providers. Available at: https://www.cdc.gov/qfever/healthcare-providers/index.html. (Accessed on November 30, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lepidi H, Fournier PE, Raoult D. Quantitative analysis of valvular lesions during Bartonella endocarditis. Am J Clin Pathol 2000; 114:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132:1435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274:1706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foucault C, Raoult D, Brouqui P. Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother 2003; 47:2204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis 2006; 12:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents 2014; 44:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vennila V, Madhu V, Rajesh R, et al. Tetracycline-induced discoloration of deciduous teeth: case series. J Int Oral Health 2014; 6:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohlan SQ, Bevelander G, Tiamsic T. Growth Inhibition of Prematures Receiving Tetracycline. Am J Dis Child 1963; 105:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cross R, Ling C, Day NP, et al. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf 2016; 15:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 2009; 23:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998; 17:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pöyhönen H, Nurmi M, Peltola V, et al. Dental staining after doxycycline use in children. J Antimicrob Chemother 2017; 72:2887.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Volovitz B, Shkap R, Amir J, et al. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr (Phila) 2007; 46:121.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Tetracyclines. In: Red Book: 2018 Report of the Committee on Infectious Diseases, 31st ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.905.
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2145 Version 18.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8458964" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7681847" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8849149" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Diagnosis of 22 new cases of Bartonella endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7795048" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Bartonella (Rochalimaea) species as a cause of apparent "culture-negative" endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8645787" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Bartonella henselae endocarditis in an immunocompetent adult.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8618486" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : New serotype of Bartonella henselae in endocarditis and cat-scratch disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8406424" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Endocarditis caused by Rochalimaea henselae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8645836" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9196420" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Culture-negative endocarditis: contribution of bartonella infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9627605" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Culture-negative endocarditis caused by Bartonella henselae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12546614" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Outcome and treatment of Bartonella endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15297484" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16390990" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : First isolation of Bartonella alsatica from a valve of a patient with endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32974498" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Bartonella clarridgeiae infection in a patient with aortic root abscess and endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31619523" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Prosthetic Valve Endocarditis with Bartonella washoensis in a Human European Patient and Its Detection in Red Squirrels (Sciurus vulgaris).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10866564" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Bartonella quintana endocarditis in a child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25540398" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Bartonella, a common cause of endocarditis: a report on 106 cases and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28348772" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Case series of Bartonella quintana blood culture-negative endocarditis in Washington, DC.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22391473" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Bartonella henselae infections in solid organ transplant recipients: report of 5 cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11470985" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22381119" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Bartonella henselae prosthetic valve endocarditis in an adult patient with congenital heart disease: favorable outcome after combined medical and surgical management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28403058" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Multiorgan Involvement Confounding the Diagnosis of Bartonella henselae Infective Endocarditis in Children With Congenital Heart Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24896298" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Bartonella henselae endocarditis and glomerulonephritis with dominant C3 deposition in a 21-year-old male with a Melody transcatheter pulmonary valve: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22301474" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Bartonella vinsonii endocarditis in an adolescent with congenital heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37138445" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11897074" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prosthetic valve endocarditis caused by Bartonella quintana.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16077432" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Bartonella species-induced prosthetic valve endocarditis associated with rapid progression of valvular stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24332768" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Bartonella endocarditis-associated glomerulonephritis: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26819786" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Necrotizing ANCA-Positive Glomerulonephritis Secondary to Culture-Negative Endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27885316" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Bartonella Endocarditis and Pauci-Immune Glomerulonephritis: A Case Report and Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30210883" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Bartonella Endocarditis Mimicking Crescentic Glomerulonephritis with PR3-ANCA Positivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30151411" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Bartonella Infectious Endocarditis Associated With Cryoglobulinemia and Multifocal Proliferative Glomerulonephritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29043145" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : ANCA-associated pauci-immune glomerulonephritis in a patient with bacterial endocarditis: a challenging clinical dilemma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24488854" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Human bartonella infective endocarditis is associated with high frequency of antiproteinase 3 antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9817529" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12093675" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15879906" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20540619" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20540619" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15155180" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Recommendations for treatment of human infections caused by Bartonella species.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17554119" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1435899" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24930039" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Service evaluation to establish the sensitivity, specificity and additional value of broad-range 16S rDNA PCR for the diagnosis of infective endocarditis from resected endocardial material in patients from eight UK and Ireland hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12624010" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12522046" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Western immunoblotting for Bartonella endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23535757" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23535757" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11338477" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Quantitative analysis of valvular lesions during Bartonella endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15956145" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26373316" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7474277" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12821469" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16494745" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Bartonella quintana characteristics and clinical management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24933445" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Pathogenicity and treatment of Bartonella infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16572105" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25083046" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Tetracycline-induced discoloration of deciduous teeth: case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Growth Inhibition of Prematures Receiving Tetracycline
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26680308" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19228311" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9613662" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Doxycycline and staining of permanent teeth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29091225" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Dental staining after doxycycline use in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17325084" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Absence of tooth staining with doxycycline treatment in young children.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
